Authors
-
Marjan Assef
University of North Carolina at Greensboro, Joint School of Nanoscience and Nano Engineering, North Carolina, USA
Author
-
Ayesha Liaquat
Karachi Medical and Dental College, Karachi, Pakistan
Author
-
Tejal Parmar
Vydehi Institute of Medical Sciences and Research Centre, Banglore, India
Author
-
Sonam LNU
Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
Author
-
Sigmone
Fatima Jinnah Medical College, Lahore, Pakistan
Author
-
Roohi Khan
Rajiv Gandhi University of Health Sciences, India
Author
-
Zeynab Salehpour
Clinical Research Development Unit Beheshti Haspital, Yasuj University of Medical Sciences, Yasuj, Iran
Author
-
Zain Abdin
MD, Premier Physicians Delaware, USA
Author
Keywords:
Antiplatelet Therapy, Acute Ischemic Stroke
Abstract
Stroke is the second greatest cause of mortality and one of the top causes of long-term disability. The fatality rate and age-adjusted prevalence of stroke have decreased globally over the past quarter-century. However, the absolute number of stroke cases has climbed, as populations have grown older. Initiating antiplatelet medications early in patients with acute ischemic stroke (AIS) is essential for preventing stroke recurrence. Aspirin, clopidogrel, and dipyridamole are the most commonly used antiplatelet medications worldwide. Combining antiplatelet drugs is associated with an increased risk of bleeding when used for long-term prophylaxis. The use of Dual antiplatelet treatment (DAPT) for a shorter duration is associated with a lower risk than long-term usage. The best period of treatment for transient ischemic attack (TIA) and mild ischemic stroke appears to be between 21 and 30 days.
Author Biographies
-
Marjan Assef, University of North Carolina at Greensboro, Joint School of Nanoscience and Nano Engineering, North Carolina, USA
Marjan Assefi, University of North Carolina at Greensboro, Joint School of Nanoscience and Nano Engineering, North Carolina, USA
-
Ayesha Liaquat, Karachi Medical and Dental College, Karachi, Pakistan
Karachi Medical and Dental College, Karachi, Pakistan.
-
Tejal Parmar, Vydehi Institute of Medical Sciences and Research Centre, Banglore, India
Vydehi Institute of Medical Sciences and Research Centre, Banglore, India.
-
Sonam LNU, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.
-
Sigmone, Fatima Jinnah Medical College, Lahore, Pakistan
Fatima Jinnah Medical College, Lahore, Pakistan.
-
Roohi Khan, Rajiv Gandhi University of Health Sciences, India
Rajiv Gandhi University of Health Sciences, India.
-
Zeynab Salehpour, Clinical Research Development Unit Beheshti Haspital, Yasuj University of Medical Sciences, Yasuj, Iran
Clinical Research Development Unit Beheshti Haspital, Yasuj University of Medical Sciences, Yasuj, Iran.
-
Zain Abdin, MD, Premier Physicians Delaware, USA
MD, Premier Physicians Delaware, USA.
